Discovery - University of Dundee - Online Publications

Library & Learning Centre

Oncogene

1 - 60 out of 60Page size: 100
Sort by: Publication year
  1. p53 is activated in response to disruption of the pre-mRNA splicing machinery

    Allende-Vega, N., Dayal, S., Agarwala, U., Sparks, A., Bourdon, J-C. & Saville, M. K. 3-Jan-2013 In : Oncogene. 32, 1, p. 1-14, 14 p.

    Research output: Contribution to journalArticle

  2. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

    Bernard, H., Garmy-Susini, B., Ainaoui, N., Van Den Berghe, L., Peurichard, A., Javerzat, S., Bikfalvi, A., Lane, D. P., Bourdon, J. C. & Prats, A-C. 25-Jun-2012 In : Oncogene.

    Research output: Contribution to journalArticle

  3. Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia

    Ånensen, N., Hjelle, S. M., Van Belle, W., Haaland, I., Silden, E., Bourdon, J-C., Hovland, R., Taskén, K., Knappskog, S., Lønning, P. E., Bruserud, O. & Gjertsen, B. T. 22-Mar-2012 In : Oncogene. 31, 12, p. 1533-1545, 13 p.

    Research output: Contribution to journalArticle

  4. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances

    Muller, P., Ruckova, E., Halada, P., Coates, P. J., Hrstka, R., Lane, D. P. & Vojtesek, B. 2012 In : Oncogene.

    Research output: Contribution to journalArticle

  5. HIF-independent role of prolyl hydroxylases in the cellular response to amino acids

    Durán, R. V., Mackenzie, E. D., Boulahbel, H., Frezza, C., Heiserich, L., Tardito, S., Bussolati, O., Rocha, S., Hall, M. N. & Gottlieb, E. 2012 In : Oncogene. 12 p.

    Research output: Contribution to journalArticle

  6. The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage

    Nicol, S. M., Bray, S. E., Derek Black, H., Lorimore, S. A., Wright, E. G., Lane, D. P., Meek, D. W., Coates, P. J. & Fuller-Pace, F. V. 2012 In : Oncogene.

    Research output: Contribution to journalArticle

  7. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma

    Watt, S., Pourreyron, C., Purdie, K., Hogan, C., Cole, C. L., Foster, N., Pratt, N., Bourdon, J-C., Appleyard, V., Murray, K., Thompson, A., Mao, X., Mein, C., Bruckner-Tuderman, L., Evans, A., McGrath, J. A., Proby, C. M., Foerster, J., Leigh, I. & South, A. Nov-2011 In : Oncogene. 30, 46, p. 4666-4677, 12 p.

    Research output: Contribution to journalArticle

  8. Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors

    Dalvai, M., Mondesert, O., Bourdon, J-C., Ducommun, B. & Dozier, C. 12-May-2011 In : Oncogene. 30, 19, p. 2282-2288, 7 p.

    Research output: Contribution to journalArticle

  9. Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility

    Preston, R. S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A. B., Dunlop, E. A., Harper, K. T., Brinkhuizen, T., Menko, F. H., Davies, D. M., Land, S. C., Pause, A., Baar, K., van Steensel, M. A. M. & Tee, A. R. Mar-2011 In : Oncogene. 30, 10, p. 1159-1173, 15 p.

    Research output: Contribution to journalArticle

  10. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

    Henry, L. A., Johnson, D. A., Sarrio, D., Lee, S., Quinlan, P. R., Crook, T., Thompson, A. M., Reis-Filho, J. S. & Isacke, C. M. Mar-2011 In : Oncogene. 30, 9, p. 1046-1058, 13 p.

    Research output: Contribution to journalArticle

  11. Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol

    Radulescu, S., Ridgway, R. A., Appleton, P., Kroboth, K., Patel, S., Woodgett, J., Taylor, S., Nathke, I. S. & Sansom, O. J. Dec-2010 In : Oncogene. 29, 49, p. 6418-6427, 10 p.

    Research output: Contribution to journalArticle

  12. The RNA helicase p68 modulates expression and function of the Delta 133 isoform(s) of p53, and is inversely associated with Delta 133p53 expression in breast cancer

    Moore, H. C., Jordan, L. B., Bray, S. E., Baker, L., Quinlan, P. R., Purdie, C. A., Thompson, A. M., Bourdon, J-C. & Fuller-Pace, F. V. Dec-2010 In : Oncogene. 29, 49, p. 6475-6484, 10 p.

    Research output: Contribution to journalArticle

  13. Enhanced mRNA cap methylation increases Cyclin D1 expression and promotes cell transformation

    Cowling, V. H. 11-Feb-2010 In : Oncogene. 29, 6, p. 930-936, 7 p.

    Research output: Contribution to journalArticle

  14. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN

    Davidson, L., Maccario, H., Perera, N. M., Yang, X., Spinelli, L., Tibarewal, P., Glancy, B., Gray, A., Weijer, C. J., Downes, C. P. & Leslie, N. R. 4-Feb-2010 In : Oncogene. 29, 5, p. 687-697, 11 p.

    Research output: Contribution to journalArticle

  15. MdmX is a substrate for the deubiquitinating enzyme USP2a

    Allende-Vega, N., Sparks, A., Lane, D. P. & Saville, M. K. 21-Jan-2010 In : Oncogene. 29, 3, p. 432-441, 10 p.

    Research output: Contribution to journalArticle

  16. The DEAD-box protein p72 regulates ER alpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ER alpha-positive breast cancer

    Wortham, N. C., Ahamed, E., Nicol, S. M., Thomas, R. S., Periyasamy, M., Jiang, J., Ochocka, A. M., Shousha, S., Huson, L., Bray, S. E., Coombes, R. C., Ali, S. & Fuller-Pace, F. V. 19-Nov-2009 In : Oncogene. 28, 46, p. 4053-4064, 12 p.

    Research output: Contribution to journalArticle

  17. Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors

    Cole, M. D. & Cowling, V. H. 5-Mar-2009 In : Oncogene. 28, 9, p. 1169-1175, 7 p.

    Research output: Contribution to journalArticle

  18. TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation

    Fleming, Y. M., Ferguson, G. J., Spender, L. C., Larsson, J., Karlsson, S., Ozanne, B. W., Grosse, R. & Inman, G. J. 19-Feb-2009 In : Oncogene. 28, 7, p. 983-993, 11 p.

    Research output: Contribution to journalArticle

  19. Understanding PTEN regulation: PIP, polarity and protein stability

    Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L. & Downes, C. P. 15-Sep-2008 In : Oncogene. 27, 41, p. 5464-5476, 13 p.

    Research output: Contribution to journalArticle

  20. The regulatory beta-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis

    Yde, C. W., Olsen, B. B., Meek, D., Watanabe, N. & Guerra, B. 28-Aug-2008 In : Oncogene. 27, 37, p. 4986-4997, 12 p.

    Research output: Contribution to journalArticle

  21. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer

    McCracken, S. R. C., Ramsay, A., Heer, R., Mathers, M. E., Jenkins, B. L., Edwards, J., Robson, C. N., Marquez, R., Cohen, P. & Leung, H. Y. 8-May-2008 In : Oncogene. 27, 21, p. 2978-2988, 11 p.

    Research output: Contribution to journalArticle

  22. An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II

    Cowling, V. H. & Cole, M. D. 21-Feb-2008 In : Oncogene. 27, 9, p. 1327-1332, 6 p.

    Research output: Contribution to journalArticle

  23. Drosophila asymmetric division, polarity and cancer

    Januschke, J. & Gonzalez, C. 2008 In : Oncogene. 27, 55, p. 6994-7002, 9 p.

    Research output: Contribution to journalArticle

  24. Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling

    Lackey, J., Barnett, J., Davidson, L., Batty, I. H., Leslie, N. R. & Downes, C. P. Nov-2007 In : Oncogene. 26, 50, p. 7132-7142, 11 p.

    Research output: Contribution to journalArticle

  25. Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1

    Roche, K. C., Rocha, S., Bracken, C. P. & Perkins, N. D. 5-Jul-2007 In : Oncogene. 26, 31, p. 4523-30, 8 p.

    Research output: Contribution to journalArticle

  26. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases

    Owens, D. M. & Keyse, S. M. 2007 In : Oncogene. 26, 22, p. 3203-13, 11 p.

    Research output: Contribution to journalArticle

  27. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation

    Cowling, V. H. & Cole, M. D. 2007 In : Oncogene. 26, 24, p. 3582-6, 5 p.

    Research output: Contribution to journalArticle

  28. HIF-1 contributes to tumour-selective killing by the sigma receptor antagonist rimcazole

    Achison, M., Boylan, M. T., Hupp, T. R. & Spruce, B. A. 2007 In : Oncogene. 26, 8, p. 1137-1146, 10 p.

    Research output: Contribution to journalArticle

  29. Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

    Allende-Vega, N., Saville, M. K. & Meek, D. W. 2007 In : Oncogene. 26, 29, p. 4234-4242, 9 p.

    Research output: Contribution to journalArticle

  30. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6

    Camus, S., Menendez, S., Cheok, C. F., Stevenson, L. F., Lain, S. & Lane, D. P. 2007 In : Oncogene. 26, 28, p. 4059-4070, 12 p.

    Research output: Contribution to journalArticle

  31. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF

    Dias, S. S., Milne, D. M. & Meek, D. W. Oct-2006 In : Oncogene. 25, 50, p. 6666-6671, 6 p.

    Research output: Contribution to journalArticle

  32. A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design

    Warbrick, E. 2006 In : Oncogene. 25, 20, p. 2850-2859, 10 p.

    Research output: Contribution to journalArticle

  33. The 'regulatory' β-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation

    Bjørling-Poulsen, M., Siehler, S., Wiesmüller, L., Meek, D., Niefind, K. & Issinger, O-G. 8-Sep-2005 In : Oncogene. 24, 40, p. 6194-6200, 7 p.

    Research output: Contribution to journalArticle

  34. Wild-type p53 activates SAP expression in lymphoid cells

    Nagy, N., Takahara, M., Nishikawa, J., Bourdon, J. C., Kis, L. L., Klein, G. & Klein, E. 2004 In : Oncogene. 23, 53, p. 8563-8570, 8 p.

    Research output: Contribution to journalArticle

  35. Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target

    Tullo, A., Mastropasqua, G., Bourdon, J. C., Centonze, P., Gostissa, M., Costanzo, A., Levrero, M., Del Sal, G., Saccone, C. & Sbisa, E. 27-Nov-2003 In : Oncogene. 22, 54, p. 8738-8748, 11 p.

    Research output: Contribution to journalArticle

  36. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX

    Mac Partlin, M., Homer, E., Robinson, H., McCormick, C. J., Crouch, D. H., Durant, S. T., Matheson, E. C., Hall, A. G., Gillespie, D. A. F. & Brown, R. Feb-2003 In : Oncogene. 22, 6, p. 819-825, 7 p.

    Research output: Contribution to journalArticle

  37. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation

    Lorimore, S. A., Coates, P. J. & Wright, E. G. 2003 In : Oncogene. 22, 45, p. 7058-69, 12 p.

    Research output: Contribution to journalScientific review

  38. Cell type-specific responses of human cells to inhibition of replication licensing

    Shreeram, S., Sparks, A., Lane, D. P. & Blow, J. J. 2002 In : Oncogene. 21, 43, p. 6624-6632, 9 p.

    Research output: Contribution to journalArticle

  39. Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours

    Causevic, M., Hislop, R. G., Kernohan, N. M., Carey, F. A., Kay, R. A., Steele, R. J. C. & Fuller-Pace, F. V. Nov-2001 In : Oncogene. 20, 53, p. 7734-7743, 10 p.

    Research output: Contribution to journalArticle

  40. Induction of endogenous β-galactosidase by ionizing radiation complicates the analysis of p53-LacZ transgenic mice

    Coates, P., Lorimore, S., Rigat, B. A., Lane, D. & Wright, E. Oct-2001 In : Oncogene. 20, 48, p. 7096-7097, 2 p.

    Research output: Contribution to journalArticle

  41. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo

    Xirodimas, D., Saville, M. K., Edling, C., Lane, D. & Lain, S. 2001 In : Oncogene. 20, 36, p. 4972-4983, 12 p.

    Research output: Contribution to journalArticle

  42. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo

    Wallace, M., Coates, P. J., Wright, E. G. & Ball, K. L. 2001 In : Oncogene. 20, 28, p. 3597-3608, 12 p.

    Research output: Contribution to journalArticle

  43. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?

    Lorimore, S., Coates, P., Scobie, G. E., Milne, G. & Wright, E. 2001 In : Oncogene. 20, 48, p. 7089-7095, 7 p.

    Research output: Contribution to journalArticle

  44. Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis

    Deguin-Chambon, V., Vacher, M., Jullien, M., May, E. & Bourdon, J-C. 30-Nov-2000 In : Oncogene. 19, 51, p. 5831-5841, 11 p.

    Research output: Contribution to journalArticle

  45. IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects

    Behrend, L., Milne, D. M., Stöter, M., Deppert, W., Campbell, L. E., Meek, D. W. & Knippschild, U. 9-Nov-2000 In : Oncogene. 19, 47, p. 5303-13, 11 p.

    Research output: Contribution to journalArticle

  46. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin

    Sánchez-Pérez, I., Martínez-Gomariz, M., Williams, D., Keyse, S. M. & Perona, R. 26-Oct-2000 In : Oncogene. 19, 45, p. 5142-52, 11 p.

    Research output: Contribution to journalArticle

  47. Mechanisms of switching on p53: a role for covalent modification?

    Meek, D. W. 13-Dec-1999 In : Oncogene. 18, 53, p. 7666-7675, 10 p.

    Research output: Contribution to journalArticle

  48. Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification

    Jardine, L. J., Milne, D. M., Dumaz, N. & Meek, D. W. 9-Dec-1999 In : Oncogene. 18, 52, p. 7602-7607, 6 p.

    Research output: Contribution to journalArticle

  49. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia

    Evans, M. F., Koreth, J., Bakkenist, C. J., Herrington, C. S. & McGee, J. O. D. 1998 In : Oncogene. 16, 19, p. 2557-2564, 8 p.

    Research output: Contribution to journalArticle

  50. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs

    Knippschild, U., Milne, D. M., Campbell, L. E., DeMaggio, A. J., Christenson, E., Hoekstra, M. F. & Meek, D. W. 2-Oct-1997 In : Oncogene. 15, 14, p. 1727-1736, 10 p.

    Research output: Contribution to journalArticle

  51. Further characterisation of the p53 responsive element - identification of new candidate genes for trans-activation by p53

    Bourdon, J-C., Deguin-Chambon, V., Lelong, J-C., Dessen, P., May, P., Debuire, B. & May, E. 1997 In : Oncogene. 14, 1, p. 85-94, 10 p.

    Research output: Contribution to journalArticle

  52. p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage

    Knippschild, U., Milne, D. M., Campbell, L. & Meek, D. 3-Oct-1996 In : Oncogene. 13, 7, p. 1387-1393, 7 p.

    Research output: Contribution to journalArticle

  53. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate

    Milne, D. M., McKendrick, L., Jardine, L. J., Deacon, E., Lord, J. M. & Meek, D. W. 4-Jul-1996 In : Oncogene. 13, 1, p. 205-211, 7 p.

    Research output: Contribution to journalArticle

  54. Characterisation of the interaction between PCNA and Gadd45

    Hall, P. A., Kearsey, J. M., Coates, P. J., Norman, D. G., Warbrick, E. & Cox, L. S. 1995 In : Oncogene. 10, 12, p. 2427-2433, 7 p.

    Research output: Contribution to journalArticle

  55. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1

    Kearsey, J. M., Coates, P. J., Prescott, A. R., Warbrick, E. & Hall, P. A. 1995 In : Oncogene. 11, 9, p. 1675-1683, 9 p.

    Research output: Contribution to journalArticle

  56. The conformational change of a murine temperature-sensitive p53 protein is independent of a change in phosphorylation status

    Picksley, S. M., Meek, D. W. & Lane, D. P. Aug-1992 In : Oncogene. 7, 8, p. 1649-1651, 3 p.

    Research output: Contribution to journalArticle

  57. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme

    Milne, D. M., Palmer, R. H., Campbell, D. G. & Meek, D. W. Jul-1992 In : Oncogene. 7, 7, p. 1361-1369, 9 p.

    Research output: Contribution to journalArticle

  58. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis

    Pritchard-Jones, K. & Fleming, S. 1991 In : Oncogene. 6, 12, p. 2211-20, 10 p.

    Research output: Contribution to journalArticle

Library & Learning Centre

Contact | Accessibility | Policy